CTRI/2022/11/047606已完成2 期
Randomised double blind,placebo controlled evaluation of NANO KANCHANAR (Bauhinia variegata Linn)HYDRO ALCOHOLIC EXTRACT in HYPOTHYROIDISM
Dean Faculty Of Ayurved Parul University0 个研究点目标入组 76 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 76
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a) Age: From 18 Year(s) Age To 60 Year(s) (inclusive of either age)
- •b) Gender: Both
- •c) Patients already diagnosed as hypothyroidism with/without medication
- •d) Patients with primary hypothyroidism
- •e) Patients with subclinical hypothyroidism
排除标准
- •a) Patients who have undergone any type of thyroid surgery.
- •b) Patients suffering from systemic diseases like IHD, PCOD, uncontrolled Diabetes Mellitus, uncontrolled
- •c) Immuno compromised diseases like HIV etc.
- •d) Patients suffering from congenital hypothyroidism
- •e) Pregnant and lactating women
研究者
相似试验
已完成
2 期
Effect of Three Turmeric- Boswellia Formulations in Exercise Induced Body PaiCTRI/2021/02/031142Arjuna Natural Private Limited200
进行中（未招募）
不适用
A double blind, randomized, placebo controlled, parallel group dose range exploration study of Sativex® in relieving pain in patients with advanced cancer, who experience inadequate analgesia during optimized chronic opioid therapy.Pain in patients with advanced cancer, who experience inadequate analgesia during optimized chronic opioid therapy.EUCTR2007-005225-30-DEGW Pharma Ltd.336
进行中（未招募）
1 期
A double blind, randomized, placebo controlled, parallel group dose range exploration study of Sativex® in relieving pain in patients with advanced cancer, who experience inadequate analgesia during optimized chronic opioid therapy.Estudio doble ciego, aleatorizado, controlado con placebo y en grupos paralelos de búsqueda de dosis de Sativex® para el alivio del dolor en pacientes con cáncer avanzado y analgesia insuficiente durante el tratamiento optimizado permanente con opiáceos.Pain in patients with advanced cancer, who experience inadequate analgesia during optimized chronic opioid therapy.Dolor en pacientes con cancer avanzado que no gozan de suficiente analgesia durante el tratamiento optimizado permanente con opiáceos.EUCTR2007-005225-30-ESGW Pharma Ltd.336
进行中（未招募）
1 期
A double blind, randomized, placebo controlled, parallel group dose range exploration study of Sativex® in relieving pain in patients with advanced cancer, who experience inadequate analgesia during optimized chronic opioid therapy.Pain in patients with advanced cancer, who experience inadequate analgesia during optimized chronic opioid therapy.EUCTR2007-005225-30-FRGW Pharma Ltd.336
已完成
3 期
A clinical trial to study the effects of Crofelemer tablets in the treatment of watery diarrhea in hospitalized adult patients.CTRI/2011/11/002156Glenmark Pharmaceuticals Limited717